Brain inflammation links to thinking speed in MS over time

Credibility

Interest

Share:2 min read

Key Takeaway

Ongoing brain inflammation seen on a special scan predicts slower thinking speed over years in people with MS.

What They Found

Researchers used a brain scan that lights up activated support cells (glia) and a simple test that measures how fast someone matches symbols to numbers (SDMT). At the first visit, damage seen in normal-looking white matter, inflammation in a deep brain area called the thalamus, and older age were linked to slower test scores. When they looked years later, inflammation in the normal-looking white matter was the best predictor of who would get slower on the thinking test. Scans that showed inflammation around some MS lesions (rim lesions) helped predict which people would have a meaningful drop in their scores. In short, more widespread, long-lasting inflammation in areas that look normal on regular scans was tied to future decline in how quickly people process information.

Who Should Care and Why

People with MS and their caregivers should care because this study suggests a hidden kind of inflammation may explain why thinking gets slower even when regular scans look 'okay' — like rust forming inside machinery you can't see. Knowing this could help doctors focus on treatments that reduce chronic inflammation, not just new relapses, which might protect thinking speed over time. Caregivers can use this idea to watch for small, gradual changes in daily tasks (for example, taking longer to follow a recipe or respond in conversation) and share these with the care team. Neurologists and MS specialists might consider using newer imaging or tests to spot this hidden inflammation and monitor treatment effects. Overall, it points to paying attention to thinking speed as part of routine care, not only physical symptoms.

Important Considerations

The study used a special PET scan on 48 people and repeated the thinking test years later in 34 people, so the group is fairly small and findings need confirmation in larger studies. This research shows an association (a link) but cannot prove the inflammation caused the thinking decline — other unmeasured factors might play a role. Also, the PET method and the specific tracer used are research tools that are not widely available in all clinics, so these exact scans may not be an option for everyone yet.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Early Research Specific Symptoms

Article Topics:

Multiple sclerosisPETSDMTTSPOcognitionimaginginformation processing speedmicrogliapositron emission tomography

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News